Home / World

Clinical trials underway for hepatitis B vaccine

By Xinhua in Havana | China Daily | Updated: 2015-08-13 07:53

A new Cuban-made vaccine against chronic hepatitis B has entered clinical trials in Cuba plus eight countries and regions in Oceania and Asia with the help of French company Abivax.

HeberNasvac, developed by the Cuban Center for Genetic Engineering and Biotechnology in Havana and administered through nasal and subcutaneous injections, is "more effective and safer than the other existing methods in the world" against this illness, Iris Lugo Carro, a specialist in CIGB's Communication Group, told state daily Granma on Tuesday.

The clinical evaluation studies were approved by regulatory authorities in Australia, New Zealand, South Korea, Singapore, the Philippines, Thailand and China's Taiwan and Hong Kong, the expert said.

Clinical trials underway for hepatitis B vaccine

Today's Top News

Editor's picks

Most Viewed

Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349